Schedule 13D ownership disclosure

ITEOS THERAPEUTICS INC

Security class unavailable · CUSIP: 46565G104

Event date: 2020-07-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,417,259
Percent of class
13.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-090872
Form type
SC 13D
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Aug 05, 2020
Reporting period
Jul 28, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub